Japan's Ministry of Health and Labor approved the manufacture and sale of a new vaccine against COVID-19 Omicron strain on the 12th. The vaccine is also expected to be effective on the current domestic epidemic subtype "BA.5". The vaccine group meeting held on the 14th will formally decide to implement free vaccination and start the work of distribution to local governments after the 19th. Starting from the people over the age of 60 and medical staff who are listed as the fourth dose of vaccination, start the vaccination work. The products approved this time are products developed by Pfizer Inc and Modena in the United States.